ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Bayer’s Regorafenib is the First Drug to Enter GBM AGILE
November 19, 2018The Global Coalition for Adaptive Research (GCAR) and Bayer announced that Bayers regorafenib will be the first drug to -
Five therapies endorsed for use on NHS Scotland
July 09, 2018A new treatment option for the very rare condition infantile onset 5q spinal muscular atrophy (type I SMA) is among five medicines that have been endorsed by Scottish cost regulators for use on the NHS. -
NICE gives final draft guidance on two key cancer drugs
October 13, 2017NICE has announced it has published its final draft guidance for two cancer treatments, covering Bayer’s Stivarga (regorafenib) in the treatment of gastrointestinal stromal tumours (GIST -
Bayer receives EU approval for Regorafenib
August 09, 2017Bayer have announced the European Commission has granted marketing authorisation for Stivarga…
Pharma Sources Insight January 2025
